EUVIMEDEUVIMED entdecken
Evaluationsstudie

Evaluating the Performance of the Paris System in Neobladder Cytology: The Role of Cellularity and Volume Adequacy Criteria

Atousa Ordobazari, Reza Nikfar, Xing Zhao, Elizabeth Davaro iD, Sara Niyazi, Jamie E Rogers, Jasreman Dhillon iD, Biwei Cao, Roger Li, Philippe E Spiess, Julio M Pow-Sang, Adebowale Adeniran und 2 weitere

Diagnostic Cytopathology · 2026

DOI: 10.1002/dc.70087 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Diagnostic Cytopathology, 2026. Verfasst von Atousa Ordobazari und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cytodiagnosis. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urinary diversion (UD) including neobladder (NB) samples play a crucial role in diagnosing recurrent urothelial carcinoma (UC) following cystectomy. However, urine cytology (UCy) interpretation in this setting is challenging due to degenerative changes and a necroinflammatory background. The diagnostic performance of UCy using The Paris System (TPS) has not been well established for NB specimens. Moreover, given the distinct characteristics of NB samples compared to other urine specimens, the application of specific adequacy criteria may be necessary.

Methods

This retrospective study analyzed 442 NB urine specimens from 243 patients who underwent cystectomy with UD. One‐year surgical pathology or cytology follow up was collected. All specimens were prepared using the cytospin technique, stained with Papanicolaou stain, and assessed using TPS criteria. The presence of preserved benign urothelial cells and urine volume were analyzed to determine specimen adequacy. Youden's index and likelihood ratio testing were applied to identify an optimal volume cutoff.

Results

By applying TPS, positive cytologic diagnoses (atypical or higher) were identified in 3.39% of NB specimens. Among 139 cases with histological or cytological follow‐up, UC was confirmed in 10.8%, with 86% being high‐grade UC (HGUC). The sensitivity and specificity of TPS for detecting HGUC were 61.5% and 96.8%, respectively. Notably, 60.5% of NB specimens in this cohort lacked preserved urothelial cells. Redefining adequacy criteria to require the presence of at least one preserved urothelial cell markedly increased sensitivity (100%) with only modest changes in specificity and overall diagnostic accuracy. A specimen volume ≥ 45 mL emerged as the optimal cutoff for identifying atypical urothelial cells or higher TPS categories, although statistical significance remained limited ( p = 0.12). Applying this threshold led to a modest improvement in the sensitivity of UD cytology (66.67%).

Conclusions

The diagnostic performance of TPS for NB samples was comparable to the performance of pre‐TPS cytology in the UD setting, as reported by other studies. Incorporating adequacy criteria based on the presence of at least one preserved benign urothelial cell substantially improves the sensitivity of UCy in NB samples. Additionally, a minimum specimen volume of approximately 45 mL may serve as an adequacy indicator for NB cytology, although its impact on diagnostic performance is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCytodiagnosisHumansFemaleMaleRetrospective StudiesAgedMiddle AgedUrotheliumCystectomyAged, 80 and overUrine

Stichwörter der Autor:innen

Paris systemadequacycellularitycytologyneobladderurineurine diversionvolume

Autor:innen und Institutionen

  • Department of Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, Florida, USA.

ORCID-Profile: Elizabeth Davaro, Jasreman Dhillon, Aram Vosoughi

Zitieren

APA

Ordobazari, A., Nikfar, R., Zhao, X., Davaro, E., Niyazi, S., Rogers, J. E., Dhillon, J., Cao, B., Li, R., Spiess, P. E., Pow-Sang, J. M., Adeniran, A., Jorda, M., & Vosoughi, A. (2026). Evaluating the Performance of the Paris System in Neobladder Cytology: The Role of Cellularity and Volume Adequacy Criteria. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70087

Vancouver

Ordobazari A, Nikfar R, Zhao X, Davaro E, Niyazi S, Rogers JE, et al. Evaluating the Performance of the Paris System in Neobladder Cytology: The Role of Cellularity and Volume Adequacy Criteria. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70087

BibTeX
@article{Ordobazari2026,
  author = {Ordobazari, Atousa and Nikfar, Reza and Zhao, Xing and Davaro, Elizabeth and Niyazi, Sara and Rogers, Jamie E and Dhillon, Jasreman and Cao, Biwei and Li, Roger and Spiess, Philippe E and Pow-Sang, Julio M and Adeniran, Adebowale and Jorda, Merce and Vosoughi, Aram},
  title = {Evaluating the Performance of the Paris System in Neobladder Cytology: The Role of Cellularity and Volume Adequacy Criteria},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  doi = {10.1002/dc.70087}
}
Kostenlos starten →